NICE rebuffs PCTs’ call to help identify more areas for savings

Andrew Dillon the chief executive of the National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

The National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here